x
Breaking News
0

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Gilead's earnings

Delivery Method

Status

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
72.11 -0.23    -0.32%
19:59:59 GMT - Closed. Currency in USD ( Disclaimer )
After Hours
72.12
+0.01
+0.02%
20:43:59 GMT - Real-time Data
Type: Equity
Market: United States
ISIN: US3755581036 
CUSIP: 375558103
  • Volume: 5,734,297
  • Bid/Ask: 72.00 / 72.24
  • Day's Range: 71.83 - 72.63
START TRADING NOW
Gilead 72.11 -0.23 -0.32%

GILD Overview

 
Information about the Gilead Sciences Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close72.34
Day's Range71.83 - 72.63
Revenue28.47B
Open72.32
52 wk Range63.76 - 82.1
EPS9.21
Volume5,734,297
Market Cap94.47B
Dividend (Yield)1.98 (2.88%)
Average Vol. (3m)8,799,544
P/E Ratio7.85
Beta1.24
1-Year Change - 10.36%
Shares Outstanding1,305,926,217
Next Earnings DateOct 30, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Strong Sell Neutral Buy
Technical Indicators Strong Sell Sell Strong Sell Strong Sell Strong Sell
Summary Strong Sell Strong Sell Strong Sell Sell Neutral

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Completed Patterns
Engulfing Bearish 1W 2 Jul 30, 2017
Engulfing Bearish 1H 2 Aug 18, 2017 01:00PM
Deliberation Bearish 1H 3 Aug 18, 2017 12:00PM
Three Black Crows 30 4 Aug 18, 2017 01:30PM
Two Crows 1W 6 Jul 02, 2017

Gilead Sciences Inc News & Analysis

Gilead Sciences Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 72.11 72.00 72.24 5,734,297 -0.32% USD 19:59:59  
  Mexico 1,292.00 0.00 0.00 102 +0.35% MXN 19:58:00  
  Switzerland 70.000 63.000 75.000 0 0.00% CHF 09/08  
  Switzerland 72.650 0.000 0.000 0 0.00% USD 09/08  
  Frankfurt 61.79 61.38 61.60 3,226 -0.18% EUR 17:02:00  
  Berlin 61.590 61.480 61.570 0 -2.11% EUR 06:08:00  
  TradeGate 61.54 61.23 61.38 4,494 -0.24% EUR 19:45:00  
  Munich 61.930 0.000 0.000 0 -1.12% EUR 06:03:00  
  Stuttgart 61.350 0.000 0.000 350 -0.58% EUR 19:54:00  
  Vienna 61.650 0.000 0.000 0 +0.03% EUR 15:32:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 157.50 159.50 156.72 -0.36 -0.23% 27.02M 19:59:59  
  Snap 14.01 14.25 13.26 +0.66 +4.94% 45.95M 19:59:59  
  Alibaba 167.50 169.50 164.10 +3.58 +2.18% 31.34M 19:59:59  
  Amazon.com 958.47 965.43 954.65 -2.10 -0.22% 3.26M 19:59:59  
  Tesla 347.46 354.00 345.80 -4.46 -1.27% 5.34M 19:59:59  
  Facebook 167.41 168.67 166.21 +0.50 +0.30% 14.97M 19:59:59  
  AMD 12.376 12.555 12.250 +0.036 +0.29% 37.17M 19:59:59  
  NVIDIA 161.50 164.36 159.64 +0.03 +0.02% 14.91M 19:59:59  
  Delcath 0.1497 0.2400 0.1423 -0.0183 -10.89% 274.34M 19:59:59  
  Foot Locker 34.38 36.80 34.29 -13.32 -27.92% 36.16M 19:59:59  

Gilead Sciences Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

9000

Equity Type

ORD

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
National Futures Association (United States), National Securities Depository (India), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Board of India (India), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong), Securities Investor Protection Corporation (United States) $10000 Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
0%
Bearish
100%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
Write your thoughts about Gilead Sciences Inc
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest GILD Comments

Episcopolian OptionTrader
Episcopolian1 Mar 17, 2017 1:46PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Price target raised to $110
Reply
0 0
Episcopolian OptionTrader
Episcopolian1 Mar 10, 2017 2:33PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GILD is about to announce a huge acquisition. Buy it before that happens. $100 price target!.
Reply
0 0
Danny Alasha
Danny Alasha Dec 30, 2016 5:57PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job pop star, I see head and shoulders here but despite, 2017 pick
Reply
0 0
Show more comments
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email